2017 annual financial data

Celldex Therapeutics 2017 Net margin

Celldex Therapeutics 2017 net margin with verified reported values.

Direct answer

Net margin was -730.06%.

Operating income was -121,527,000 USD and net income was -93,031,000 USD.
Operating cash flow was -99,931,000 USD.

Get free Celldex Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
12,743,000 USD
Operating income
-121,527,000 USD
Net income
-93,031,000 USD
Operating cash flow
-99,931,000 USD